xyl-20221101
0001524472false00015244722022-11-012022-11-010001524472dei:FormerAddressMember2022-11-012022-11-010001524472us-gaap:CommonStockMember2022-11-012022-11-010001524472xyl:SeniorNotesDueTwoThousandAndTwentyThreeMember2022-11-012022-11-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 1, 2022
XYLEM INC.
(Exact name of registrant as specified in its charter)
Indiana001-3522945-2080495
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
301 Water Street SE20003
WashingtonDC
(Address of principal executive offices)(Zip Code)
(202) 869-9150
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange of which registered
Common Stock, par value $0.01 per shareXYLNew York Stock Exchange
2.250% Senior Notes due 2023XYL23New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨



Item 2.02Results of Operations and Financial Condition
On November 1, 2022, Xylem Inc. issued a press release announcing its financial results for the quarter ended September 30, 2022. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated by reference herein.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01Financial Statements and Exhibits
(d) Exhibits.
Exhibit
   No.
Description
Press Release issued by Xylem Inc. on November 1, 2022.
104.0The cover page from Xylem Inc.'s Form 8-K, formatted in Inline XBRL.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
XYLEM INC.
Date: November 1, 2022By:/s/ Sandra E. Rowland
Sandra E. Rowland
Senior Vice President & Chief Financial Officer
(Authorized Officer of Registrant)



Document

Exhibit 99.1
https://cdn.kscope.io/2ab56bc45eeb311e8279861820a295ce-xylemlogoa16.jpg
Xylem Inc.
301 Water Street SE, Washington, DC 20003
Tel +1.202.869.9150


Contacts: Media Investors
Houston Spencer +1 (914) 323-5723 Andrea van der Berg +1 (202) 869-9151
houston.spencer@xylem.com andrea.vanderberg@xylem.com


Xylem Reports Third Quarter 2022 Results

Lifting full-year organic revenue growth guidance to 9% to 10%, from 8% to 10%
Raising full-year adjusted EPS guidance to $2.65 to $2.75, from $2.50 to $2.70
Third quarter revenue growth of 9% on a reported basis, 16% organically
Reported earnings per share of $0.07, adjusted earnings per share of $0.79

Washington, D.C., November 1, 2022 – Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter revenue of $1.4 billion, surpassing previous guidance, with strong commercial and operational execution. While orders were down 7 percent on a reported basis, they were down 1 percent organically, with the difference due to currency. The Company reported resilient underlying global demand with strong backlog growth.

Earnings also exceeded Xylem’s previous guidance, with strong margin performance. Net income was $12 million, or $0.07 per share. Net income margin decreased 810 basis points to 0.9 percent. These results were mainly driven by a previously announced, one-time non-cash pension plan settlement. Adjusted net income was $144 million, or $0.79 per share, which excludes the impacts of restructuring, realignment and special charges. Third quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 18.3 percent, reflecting a year-over-year increase of 40 basis points. Strong price realization offset inflation and, coupled with productivity savings, drove the margin expansion, exceeding the impact of strategic investments.

“The team delivered very strong performance across all our regions, driving third quarter results well above expectations on all key metrics,” said Patrick Decker, Xylem president and CEO. “Demand remains resilient across our largest end-markets, and disciplined operational execution delivered double-digit revenue growth with strong margin expansion.”

“We anticipate our momentum will continue driven by the essential nature of the services we provide. Our strong backlog and bidding pipelines support that outlook. The team, from our factories to our channel partners, continues to demonstrate resilience in managing through a dynamic environment, as our customers and communities invest in essential water infrastructure. Based on this strength, we are further raising our full-year guidance for both revenue and earnings per share, with continued confidence in Xylem’s longer-term growth outlook.”

Outlook

Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent, and approximately 4 percent on a reported basis. This represents a raise of the low end of the Company’s previous full-year organic revenue guidance of 8 to 10 percent, and 3 to 5 percent on a reported basis.
1


Full-year 2022 adjusted EBITDA margin is now expected to be approximately 17.0 percent, raising the low end of the previous range of 16.5 to 17.0 percent. This results in adjusted earnings per share of $2.65 to $2.75, an increase from the previous range of $2.50 to $2.70. The increased guidance reflects strong demand, gradual easing of supply chain constraints, and price realization, partially offset by inflation and foreign exchange headwinds.

Further 2022 planning assumptions are included in Xylem’s third quarter 2022 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

Third quarter 2022 revenue was $574 million, a 5 percent increase, 13 percent organically, compared with third quarter 2021. This strong growth was driven by price realization, robust utilities demand in the US and Western Europe, and dewatering demand in the US and Emerging Markets.

Third quarter reported operating income for the segment was $104 million, a 3.0 percent increase versus the comparable period last year. Adjusted operating income for the segment, which excludes $3 million of restructuring and realignment costs, was $107 million, a 4.9 percent increase versus the comparable period last year. Reported operating margin for the segment was 18.1 percent, down 40 basis points versus the prior year, and adjusted operating margin was 18.6 percent, flat versus the prior year. Adjusted EBITDA margin was 20.7 percent, down 50 basis points from the prior year. Favorable price realization net of inflation was offset by strategic investments and unfavorable mix.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

Third quarter 2022 Applied Water revenue was $458 million, a 15 percent increase, 20 percent organically, year-over-year. The robust growth was driven by strong price realization and backlog execution across all end markets.

Third quarter reported operating income for the segment was $77 million, a 28.3 percent increase versus comparable period last year, and adjusted operating income, which excludes $1 million of restructuring and realignment costs, was $78 million, a 25.8 percent increase versus the comparable period last year. The segment reported operating margin was 16.8 percent, up 180 basis points versus the prior year period. Adjusted operating margin increased 150 basis points over the prior year period to 17.0 percent. Adjusted EBITDA margin was 18.1 percent, up 110 basis points from the prior year. Margin expansion was driven by strong price realization more than offsetting inflation coupled with productivity savings.

Measurement & Control Solutions

2


Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.

Third quarter 2022 Measurement & Control Solutions revenue was $348 million, up 9 percent, 15 percent organically, versus the prior year. While chip supply remains constrained, we continue to see modest sequential improvement, and strength in our water quality test applications.

Third quarter reported operating income for the segment was $(2) million, a 128.6 percent decrease versus the comparable period last year, and adjusted operating income, which excludes $2 million of restructuring and realignment costs and $12 million of special charges, was $12 million, a 100 percent increase versus the comparable period last year. The segment reported operating margin was (0.6) percent, down 280 basis points versus the prior year period. Adjusted operating margin of 3.4 percent increased 150 basis points over the prior year period. Adjusted EBITDA margin was 13.8 percent, down 40 basis points from the prior year. Strong price realization, volume growth and productivity savings were more than offset by higher inflation.

Supplemental information on Xylem’s third quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

###

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from changes in international conditions, including as a result of the war between Russia and Ukraine, the coronavirus (“COVID-19”) pandemic and macroeconomic conditions, including inflation. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of
3


the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing impacts of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts, and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products; disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 ("2021 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

4


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
Three MonthsNine Months
For the periods ended September 30,2022202120222021
Revenue$1,380 $1,265 $4,016 $3,872 
Cost of revenue856 793 2,505 2,390 
Gross profit524 472 1,511 1,482 
Selling, general and administrative expenses294 273 912 878 
Research and development expenses47 49 152 152 
Restructuring and asset impairment charges15 (2)22 
Operating income168 152 425 445 
Interest expense12 21 37 63 
U.K. pension settlement expense140 — 140 — 
Other non-operating income, net1 2 
Gain from sale of business — 1 
Income before taxes17 133 251 385 
Income tax expense5 19 45 71 
Net income$12 $114 $206 $314 
Earnings per share:
Basic$0.07 $0.63 $1.14 $1.74 
Diluted$0.07 $0.63 $1.14 $1.73 
Weighted average number of shares:
Basic180.2 180.2 180.2 180.2 
Diluted180.9 181.6 180.9 181.5 


5


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
September 30,
2022
December 31,
2021
  
ASSETS
Current assets:
Cash and cash equivalents$1,186 $1,349 
Receivables, less allowances for discounts, returns and credit losses of $46 and $44 in 2022 and 2021, respectively
1,018 953 
Inventories837 700 
Prepaid and other current assets150 158 
Total current assets3,191 3,160 
Property, plant and equipment, net585 644 
Goodwill2,637 2,792 
Other intangible assets, net933 1,016 
Other non-current assets760 664 
Total assets$8,106 $8,276 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$618 $639 
Accrued and other current liabilities828 752 
Short-term borrowings and current maturities of long-term debt483 — 
Total current liabilities1,929 1,391 
Long-term debt1,880 2,440 
Accrued post-retirement benefits361 438 
Deferred income tax liabilities260 287 
Other non-current accrued liabilities454 494 
Total liabilities4,884 5,050 
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 196 shares and 195.6 shares in 2022 and 2021, respectively
2 
Capital in excess of par value2,123 2,089 
Retained earnings2,197 2,154 
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively
(708)(656)
Accumulated other comprehensive loss(399)(371)
Total stockholders’ equity3,215 3,218 
Non-controlling interests7 
Total equity3,222 3,226 
Total liabilities and stockholders’ equity$8,106 $8,276 

6


XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
For the nine months ended September 30,20222021
Operating Activities
Net income$206 $314 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation83 90 
Amortization93 96 
Share-based compensation28 25 
Restructuring and asset impairment charges22 
U.K. pension settlement140 — 
Gain from sale of business(1)(2)
Other, net(9)
Payments for restructuring(7)(21)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables(145)(78)
Changes in inventories(214)(135)
Changes in accounts payable47 19 
Changes in accrued taxes(12)— 
Other, net3 — 
Net Cash – Operating activities234 318 
Investing Activities
Capital expenditures(148)(127)
Proceeds from sale of business1 
Proceeds from the sale of property, plant and equipment3 
Cash received from investments5 — 
Cash received from cross-currency swaps24 11 
Cash paid for investments(9)— 
Other, net1 — 
Net Cash – Investing activities(123)(113)
Financing Activities
   Long-term debt repaid (600)
Repurchase of common stock(52)(68)
Proceeds from exercise of employee stock options6 15 
Dividends paid(163)(152)
Other, net(1)(1)
Net Cash – Financing activities(210)(806)
Effect of exchange rate changes on cash(64)(19)
Net change in cash and cash equivalents(163)(620)
Cash and cash equivalents at beginning of year1,349 1,875 
Cash and cash equivalents at end of period$1,186 $1,255 
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest$67 $83 
Income taxes (net of refunds received)$57 $71 

7


Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and “Adjusted Segment EBITDA” reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
“Adjusted EBITDA Margin” and “Adjusted Segment EBITDA Margin” defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
“Adjusted Operating Income”, “Adjusted Segment Operating Income”, “Adjusted Net Income” and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
“Adjusted Operating Margin” and “Adjusted Segment Operating Margin” defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and “Free Cash Flow Conversion” defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of “free cash flow” and “free cash flow conversion” do not consider certain non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges” defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.
“Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
8


Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
(As Reported - GAAP)(As Adjusted - Organic)
Constant 
Currency
(A)(B)(C)(D)(E)=B+C+D(F) = E/A(G) = (E - C) / A
OrdersOrdersChange 2022 v. 2021% Change 2022 v. 2021Acquisitions/
Divestitures
FX
Impact
Change
Adj.
2022 v. 2021
% Change
Adj. 2022 v. 2021
20222021
Nine Months Ended September 30
Xylem Inc.4,818 4,716 102 %18 189 309 %%
Water Infrastructure1,985 1,873 112 %— 113 225 12 %12 %
Applied Water1,394 1,409 (15)(1)%— 45 30 %%
Measurement & Control Solutions1,439 1,434 %18 31 54 %%
Quarter Ended September 30
Xylem Inc.1,419 1,518 (99)(7)%782-10(1)%(1)%
Water Infrastructure594 623 (29)(5)%— 4718%%
Applied Water409 446 (37)(8)%— 20(17)(4)%(4)%
Measurement & Control Solutions416 449 (33)(7)%715(11)(2)%(4)%
Quarter Ended June 30
Xylem Inc.1,684 1,660 24 %56796%%
Water Infrastructure731 639 92 14 %— 4213421 %21 %
Applied Water480 486 (6)(1)%— 159%%
Measurement & Control Solutions473 535 (62)(12)%510-47(9)%(10)%
Quarter Ended March 31
Xylem Inc.1,715 1,538 177 12 %64022314 %14 %
Water Infrastructure660 611 49 %— 247312 %12 %
Applied Water505 477 28 %— 1038%%
Measurement & Control Solutions550 450 100 22 %6611225 %24 %




9


Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
(As Reported - GAAP)(As Adjusted - Organic)
Constant 
Currency
(A)(B)(C)(D)(E) = B+C+D(F) = E/A(G) = (E - C) / A
RevenueRevenueChange 2022 v. 2021% Change 2022 v. 2021
Acquisitions /
Divestitures
FX
Impact
Change Adj. 2022 v. 2021% Change Adj. 2022 v. 2021
20222021
Nine Months Ended September 30
Xylem Inc.4,016 3,872 144 %173 326 %%
Water Infrastructure1,696 1,625 71 %— 99 170 10 %10 %
Applied Water1,312 1,207 105 %— 44 149 12 %12 %
Measurement & Control Solutions1,008 1,040 (32)(3)%30 %%
Quarter Ended September 30
Xylem Inc.1,380 1,265 115 %80 199 16 %15 %
Water Infrastructure574 547 27 %— 46 73 13 %13 %
Applied Water458 400 58 15 %— 21 79 20 %20 %
Measurement & Control Solutions348 318 30 %13 47 15 %14 %
Quarter Ended June 30
Xylem Inc.1,364 1,351 13 %60 76 %%
Water Infrastructure589 569 20 %— 34 54 %%
Applied Water429 414 15 %— 15 30 %%
Measurement & Control Solutions346 368 (22)(6)%11 (8)(2)%(3)%
Quarter Ended March 31
Xylem Inc.1,272 1,256 16 %33 51 %%
Water Infrastructure533 509 24 %— 19 43 %%
Applied Water425 393 32 %— 40 10 %10 %
Measurement & Control Solutions314 354 (40)(11)%(32)(9)%(10)%







10


Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
Q1Q2Q3Year-to-Date
20222021202220212022202120222021
Net Cash - Operating Activities$(81)$(26)$113 $232 $202 $112 $234 $318 
Capital Expenditures - PP&E(31)(22)(30)(25)(37)(33)(98)(80)
Capital Expenditures - Software(18)(17)(16)(16)(16)(14)(50)(47)
Capital Expenditures(49)(39)(46)(41)(53)(47)(148)(127)
Free Cash Flow$(130)$(65)$67 $191 $149 $65 $86 $191 
Net Income82 87 112 113 12 114 206 314 
Gain/(Loss) from sale of business1 —   1 
Restructuring & Realignment Charges - non-cash impairment (1) —  —  (1)
U.K. pension buyout settlement - non-cash release from AOCI —  — (140)— (140)— 
U.K. pension buyout settlement - non-cash tax release from AOCI —  — 23 — 23 — 
Special Charges - non-cash impairment (1)(1)— (12)— (13)(1)
Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items$81 $89 $113 $111 $141 $114 $335 $314 
Operating Cash Flow Conversion(99)%(30)%101 %205 %1683 %98 %114 %101 %
Free Cash Flow Conversion(160)%(73)%59 %172 %106 %57 %26 %61 %
11


Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
Q1Q2Q3YTD
20222021202220212022202120222021
Total Revenue
• Total Xylem1,272 1,256 1,364 1,351 1,380 1,265 4,016 3,872 
• Water Infrastructure533 509 589 569 574 547 1,696 1,625 
• Applied Water425 393 429 414 458 400 1,312 1,207 
• Measurement & Control Solutions314 354 346 368 348 318 1,008 1,040 
Operating Income
• Total Xylem111 133 146 160 168 152 425 445 
• Water Infrastructure74 71 108 93 104 101 286 265 
• Applied Water59 66 61 64 77 60 197 190 
• Measurement & Control Solutions(10)(5)13 (2)(17)29 
• Total Segments123 146 164 170 179 168 466 484 
Operating Margin
• Total Xylem8.7 %10.6 %10.7 %11.8 %12.2 %12.0 %10.6 %11.5 %
• Water Infrastructure13.9 %13.9 %18.3 %16.3 %18.1 %18.5 %16.9 %16.3 %
• Applied Water13.9 %16.8 %14.2 %15.5 %16.8 %15.0 %15.0 %15.7 %
• Measurement & Control Solutions(3.2)%2.5 %(1.4)%3.5 %(0.6)%2.2 %(1.7)%2.8 %
• Total Segments9.7 %11.6 %12.0 %12.6 %13.0 %13.3 %11.6 %12.5 %
Special Charges
• Total Xylem— 13 15 
• Water Infrastructure— — — — — — — — 
• Applied Water— — — — — — 
• Measurement & Control Solutions— — — 12 — 13 — 
• Total Segments— — 12 — 13 
Restructuring & Realignment Costs
• Total Xylem18 16 
• Water Infrastructure10 
• Applied Water
• Measurement & Control Solutions— (1)
• Total Segments18 16 
Adjusted Operating Income
• Total Xylem116 143 155 166 187 155 458 464 
• Water Infrastructure75 76 111 97 107 102 293 275 
• Applied Water60 68 63 66 78 62 201 196 
• Measurement & Control Solutions(8)11 (1)13 12 30 
• Total Segments127 155 173 176 197 170 497 501 
Adjusted Operating Margin
• Total Xylem9.1 %11.4 %11.4 %12.3 %13.6 %12.3 %11.4 %12.0 %
• Water Infrastructure14.1 %14.9 %18.8 %17.0 %18.6 %18.6 %17.3 %16.9 %
• Applied Water14.1 %17.3 %14.7 %15.9 %17.0 %15.5 %15.3 %16.2 %
• Measurement & Control Solutions(2.5)%3.1 %(0.3)%3.5 %3.4 %1.9 %0.3 %2.9 %
• Total Segments10.0 %12.3 %12.7 %13.0 %14.3 %13.4 %12.4 %12.9 %


12


Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q3 2022Q3 2021
As ReportedAdjustmentsAdjustedAs ReportedAdjustmentsAdjusted
Total Revenue1,380 — 1,380 1,265 — 1,265 
Operating Income168 19  a 187 152  a 155 
Operating Margin12.2 %13.6 %12.0 %12.3 %
Interest Expense(12)— (12)(21)— (21)
Other Non-Operating Income (Expense)bb
UK Pension Buyout Settlement(140)140 — — — — 
Gain/(Loss) from sale of business— — — — — — 
Income before Taxes17 160 177 133 137 
Provision for Income Taxes(5)(28)c(33)(19)(2)c(21)
Net Income attributable to Xylem12 132 144 114 116 
Diluted Shares181.0 181.0 182.0 182.0 
Diluted EPS$0.07 $0.72 $0.79 $0.63 $ $0.63 
Year-over-year currency translation impact on current year diluted EPS$0.03 $(0.17)$(0.14)
Diluted EPS at Constant Currency$0.04 $0.89 $0.93 
Q3 YTD 2022Q3 YTD 2021
As ReportedAdjustmentsAdjustedAs ReportedAdjustmentsAdjusted
Total Revenue4,016 — 4,016 3,872 — 3,872 
Operating Income425 33  a 458 445 19  a 464 
Operating Margin10.6 %— 11.4 %11.5 %12.0 %
Interest Expense(37)— (37)(63)— (63)
Other Non-Operating Income (Expense)4 b 5 b
UK Pension Buyout Settlement(140)140 — — — — 
Gain/(Loss) from sale of business(1)— (2)— 
Income before Taxes251 176 427 385 22 407 
Provision for Income Taxes(45)(34) c (79)(71) c (70)
Net Income attributable to Xylem206 142 348 314 23 337 
Diluted Shares181.0 181.0 182.0 182.0 
Diluted EPS$1.14 $0.78 $1.92 $1.73 $0.13 $1.86 
Year-over-year currency translation impact on current year diluted EPS$(0.09)$(0.17)$(0.26)
Diluted EPS at Constant Currency$1.23 $0.95 $2.18 
aQuarter-to-date: Restructuring & realignment costs of $6 million in 2022 and $2 million in 2021, as well as special charges of $13 million in 2022 ($1 million UK pension plan charges and $12 million asset impairment charges) and $1 million in 2021 for UK pension plan charges.
Year-to-date: Restructuring & realignment costs of $18 million in 2022 and $16 million in 2021, as well as special charges of $15 million in 2022 ($2 million UK pension plan charges and $13 million of asset impairment charges) in 2022 and $3 million ($1 million of intangible asset impairment charges and $2 million of other charges) in 2021.
bQuarter-to-date: Special non-operating charges consist of $141 million in 2022 related to UK pension plan charges and buyout settlement and $1 million in 2021 for costs related to the UK pension plan.
Year-to-date: Special non-operating charges consist of $144 million in 2022 related to the UK pension plan charges and buyout settlement and $5 million in 2021 for costs related to the UK pension plan.
cQuarter-to-date: Net tax impact on restructuring & realignment costs of $1 million in 2022 and $1 million in 2021; net tax impact on special charges of $25 million in 2022; and $2 million in 2022 and $1 million in 2021 of negative impact from tax related special benefits to GAAP tax, respectively.
Year-to-date: Net tax impact on restructuring & realignment costs of $4 million in 2022 and $4 million in 2021; $26 million net tax impact on special charges in 2022 and $1 million 2021; and $4 million of negative impact from tax related special benefits to GAAP tax in 2022 and $6 million of positive impact from tax related special charges to GAAP tax in 2021.
13




Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
($ Millions)
2022
Q1Q2Q3Q4Total
Net Income82 112 12 206 
Net Income Margin6.4 %8.2 %0.9 %5.1 %
Depreciation28 28 27 83 
Amortization30 32 31 93 
Interest Expense (Income), net11 10 28 
Income Tax Expense16 24 45 
EBITDA167 206 82 — 455 
Share-based Compensation10 28 
Restructuring & Realignment18 
U.K. Pension Settlement— — 140 140 
Special Charges14 19 
Loss/(Gain) from sale of business(1)— — (1)
Adjusted EBITDA181 226 252 — 659 
Revenue1,272 1,364 1,380 4,016 
Adjusted EBITDA Margin14.2 %16.6 %18.3 %16.4 %
2021
Q1Q2Q3Q4Total
Net Income87 113 114 113 427 
Net Income Margin6.9 %8.4 %9.0 %8.5 %8.2 %
Depreciation30 29 31 28 118 
Amortization32 33 31 31 127 
Interest Expense (Income), net19 19 20 11 69 
Income Tax Expense27 25 19 13 84 
EBITDA195 219 215 196 825 
Share-based Compensation33 
Restructuring & Realignment22 
Special Charges12 
Loss/(Gain) from sale of business— (2)— — (2)
Adjusted EBITDA215 234 227 214 890 
Revenue1,256 1,351 1,265 1,323 5,195 
Adjusted EBITDA Margin17.1 %17.3 %17.9 %16.2 %17.1 %











14









Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Water Infrastructure
($ Millions)
2022
Q1Q2Q3Q4Total
Operating Income74 108 104 286 
Loss/ (Gain) from sale of business— — — — 
Depreciation11 11 11 33 
Amortization
Other non-operating expense, excluding interest income(4)— (3)
EBITDA83 123 116 — 322 
Share-based Compensation— — 
Restructuring & Realignment
Adjusted EBITDA85 126 119 — 330 
Revenue533 589 574 1,696 
Adjusted EBITDA Margin15.9 %21.4 %20.7 %19.5 %
2021
Q1Q2Q3Q4Total
Operating Income71 93 101 122387 
Loss/ (Gain) from sale of business— — — — 
Depreciation11 11 11 1043 
Amortization3
Other non-operating expense, excluding interest income(2)(2)-2(5)
EBITDA82 104 114 133 433 
Share-based Compensation— — 
Restructuring & Realignment212 
Adjusted EBITDA88 108 116 135 447 
Revenue509 569 547 6222,247 
Adjusted EBITDA Margin17.3 %19.0 %21.2 %21.7 19.9 %


15


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Applied Water
($ Millions)
2022
Q1Q2Q3Q4Total
Operating Income59 61 77 197 
Loss/(Gain) from sale of business— — — — 
Depreciation13 
Amortization— — 
Other non-operating expense, excluding interest income(1)— (1)(2)
EBITDA63 66 80 — 209 
Share-based Compensation
Restructuring & Realignment
Adjusted EBITDA65 69 83 — 217 
Revenue425 429 458 1,312 
Adjusted EBITDA Margin15.3 %16.1 %18.1 %16.5 %
2021
Q1Q2Q3Q4Total
Operating Income66 64 60 50240 
Loss/(Gain) from sale of business— — — 
Depreciation520 
Amortization— — 
Other non-operating expense, excluding interest income— (1)— (2)(3)
EBITDA72 71 65 53 261 
Share-based Compensation1
Restructuring & Realignment
Special Charges— — — 
Loss/(Gain) from sale of business— (2)— — (2)
Adjusted EBITDA75 72 68 56 271 
Revenue393 414 400 4061,613 
Adjusted EBITDA Margin19.1 %17.4 %17.0 %13.8 16.8 %


16


Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Measurement & Control Solutions
($ Millions)
2022
Q1Q2Q3Q4Total
Operating Income(10)(5)(2)(17)
Loss/(Gain) from sale of business— — 
Depreciation25 
Amortization25 26 27 78 
Other non-operating expense, excluding interest income— (1)(1)(2)
EBITDA25 28 32 — 85 
Share-based Compensation
Restructuring & Realignment
Special Charges— 12 13 
Loss/(Gain) from sale of business(1)— — (1)
Adjusted EBITDA27 34 48 — 109 
Revenue314 346 348 1,008 
Adjusted EBITDA Margin8.6 %9.8 %13.8 %10.8 %
2021
Q1Q2Q3Q4Total
Operating Income13 (17)12 
Depreciation10 11 838 
Amortization27 27 27 26107 
Other non-operating expense, excluding interest income(1)(1)— — (2)
EBITDA44 49 45 17155 
Share-based Compensation2
Restructuring & Realignment— (1)2
Adjusted EBITDA47 51 45 21164 
Revenue354 368 318 295 1,335 
Adjusted EBITDA Margin13.3 %13.9 %14.2 %7.1 12.3 %

17